Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for ...

"The observed differential effects of high-efficacy disease-modifying agents across sexes underscore the importance of sex-specific considerations in making treatment decisions to personalize care in ...

TREATMENT HAS ALREADY CHANGED MILLIONS OF LIVES IN THIS BUILDING. ONE DOCTOR DISCOVERED A BREAKTHROUGH THAT IS CHANGING THE LIVES OF PEOPLE LIVING WITH MULTIPLE SCLEROSIS. THESE PATIENTS, WITH ...

Please provide your email address to receive an email when new articles are posted on . The impact of early disease is prompting more aggressive therapies. BTK ...

MS is a chronic, immune-mediated disease affecting the central nervous system, with no known cure and varying levels of impact on individuals. Over 20 FDA-approved disease-modifying therapies exist, ...

BUFFALO, N.Y. (WIVB) — More than a thousand people gathered at Terminal B at the Outer Harbor with one goal in mind Saturday morning — making the step forward toward finding a cure for multiple ...

If you’ve been recently diagnosed with SPMS, you may wonder how the transition between RRMS and SPMS will affect your MS treatment options and lifestyle. Most people with MS are initially diagnosed ...

DNA damage from inflammation outpaces the cells’ ability to self-repair. The finding, in human brain cells and mice, could ...

The world's largest brain study is underway, and findings are groundbreaking.

PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

Many women with multiple sclerosis (MS) have misconceptions about how the disease may affect pregnancy and childbirth, a ...